Tata 1mg, a well-known digital healthcare platform in India, is moving into the pet care market. They’re starting a new section called PawsNPurrs, which will offer pet meds with prescriptions, supplements, food, and grooming items. This move puts them in a ₹7,500 crore market and makes them one of the newest D2C brands in the Indian healthcare and wellness scene.
This fits with the way D2C businesses are changing in India, where healthcare and lifestyle brands are quickly growing their product lines to serve specific markets. With PawsNPurrs, Tata 1mg is growing and strengthening its D2C skills by using the same sourcing, supply chain, and cold-chain logistics that have made them a leader in online pharmacy and wellness delivery.
According to Prashant Tandon, Founder & CEO of Tata 1mg, this decision was based on clear market demand. He said that the market is big, the problems are real, and the profit margins are good. They expect to do well in this area and create a big business. By joining the D2C pet care market, Tata 1mg is dealing with real customer issues like products not being available, unreliable home delivery, and concerns about whether medicines are real. They’ve already solved these problems for human healthcare customers through their D2C business model in India.
Initially, PawsNPurrs will be available all over India in 22,000 postal codes through Tata 1mg’s current app and website. They don’t plan to create a separate app, preferring to use their current retail stores and online presence. The pet care line will include both prescription and over-the-counter products, giving pet owners a wide range of options in one convenient place.
This launch also puts Tata 1mg among the fastest-growing D2C brands in India, along with companies like NetMeds, PharmEasy, and Apollo24/7, which have already started looking into pet care. Tata 1mg’s D2C supply chain and cold-chain skills give them an advantage in keeping product quality high and making deliveries on time, which is important for medicines and supplements.
Tata 1mg’s move into the D2C pet care market could also lead to their own private-label products, similar to what they’ve done in human wellness. Tandon said that the company will think about creating its own products once it understands consumer needs better, which could help them address unmet needs and introduce specialized pet products.
The launch of PawsNPurrs shows Tata 1mg’s goal of making healthcare accessible across different categories and strengthening India’s D2C scene. As one of the top D2C business moves, this highlights the growing connection between technology, healthcare, and personalized consumer products.
By meeting the emotional and practical needs of pet owners, Tata 1mg is changing what convenience means and setting a new standard for D2C wellness startups in India. This move confirms that established companies can adapt and grow in the D2C industry, showing that the future of D2C in India is diverse and closely linked to changing lifestyle trends.
